A phase III trial of 5-fluorouracil and
โ
Michael J. O'Connell
๐
Article
๐
1989
๐
John Wiley and Sons
๐
English
โ 498 KB
๐ 2 views
The Mayo Clinic and the North Central Cancer Treatment Group (NCCTG) conducted a randomized clinical trial comparing five different combination chemotherapeutic regimens to single-agent 5-fluorouracil (5-FU), given by intravenous bolus technique (500 mg/m2 for 5 days) as a control, in the treatment